InsidersTradesSigma
Explore the complete record of transactions filed by Schwartz Jeffrey Lawrence, Director. Insider active across 2 companies, notably SpringWorks Therapeutics, Inc.. Aggregated, 3 disclosures have been published. The latest transaction was filed on 19 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations
Jeffrey Lawrence Schwartz is a Board Member at SpringWorks Therapeutics, Inc. With experience in the biopharmaceutical sector, he contributes to the strategy and governance of the company. His role is essential in ensuring innovation and performance for SpringWorks.